The legacy of Viagra, and its parent company copyright, presents a challenging case study for investors. At first a blockbuster drug, yielding billions in sales , its exclusivity period created a deluge of https://thebookmarkage.com/story21388186/viagra-and-big-pharma-a-risky-opportunity